AI for systematic review in 2026 is most useful for title-abstract screening and data extraction, where supervised machine learning can cut workload by 50 to 70 percent without raising false-negative risk above acceptable thresholds. The best AI tools for systematic review (Covidence AI, Rayyan, DistillerSR, Elicit), also covered in our AI tools for literature review roundup, all operate as decision-support layers, not replacements for dual-reviewer protocols. You can try the same approach free in our browser-based screening tool with active-learning ranking. PRISMA 2020 and Cochrane MECIR still require human accountability.
Keep a human-checkable paper trail with the screening and extraction templates.
Best AI for Systematic Review: Top Tools Compared
1. Research Gold screening tool: best free, no-account option that scales to a full platform. The browser-based screening tool ranks records by relevance with active-learning recall estimation as you decide and reconciles two independent reviewers with Cohen's kappa, then hands off to free companion tools for , , and . Free for browser screening with no signup or usage limits. Paid cloud tiers add full-text PDF screening, structured extraction, audit trails, risk of bias modules (RoB 2, ROBINS-I, NOS), GRADE, direct database retrieval (PubMed, Europe PMC, OpenAlex, Crossref, ClinicalTrials.gov, Semantic Scholar, DOAJ) with citation chasing, and 21 CFR Part 11 compliance, so the same tool serves a single student and a pharmaceutical evidence team. Pro from $99/year, Team from $390/year, Institution from $3,000/year.
